Tuesday 2 September 2014

Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors

Chief Executive of AstraZeneca Pascal Soriot leaves after appearing at a commons science committee hearing at Portcullis House in London By Ben Hirschler BARCELONA (Reuters) - Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona. "The only thing I can tell you is I am here - and imagine where I would be if something was happening!" Pascal Soriot told Reuters on the sidelines of the European Society of Cardiology congress, the world's largest heart meeting. Strict British takeover rules limit what Soriot and other players can say about Pfizer's abortive attempt to buy AstraZeneca and the possibility of a resumption of talks.




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment